nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—Fluorouracil—head and neck cancer	0.18	0.375	CbGbCtD
Estropipate—CYP1A2—Fluorouracil—head and neck cancer	0.108	0.224	CbGbCtD
Estropipate—CYP2C9—Fluorouracil—head and neck cancer	0.0973	0.202	CbGbCtD
Estropipate—CYP3A4—Vinblastine—head and neck cancer	0.0524	0.109	CbGbCtD
Estropipate—CYP3A4—Docetaxel—head and neck cancer	0.0432	0.0897	CbGbCtD
Estropipate—Ovarian cancer—Docetaxel—head and neck cancer	0.0142	0.0435	CcSEcCtD
Estropipate—Colitis ischaemic—Docetaxel—head and neck cancer	0.00839	0.0257	CcSEcCtD
Estropipate—Neuritis—Vinblastine—head and neck cancer	0.00697	0.0213	CcSEcCtD
Estropipate—Breast cancer—Docetaxel—head and neck cancer	0.00676	0.0207	CcSEcCtD
Estropipate—Blister—Hydroxyurea—head and neck cancer	0.00659	0.0201	CcSEcCtD
Estropipate—Rash generalised—Docetaxel—head and neck cancer	0.0058	0.0177	CcSEcCtD
Estropipate—Tenderness—Hydroxyurea—head and neck cancer	0.00544	0.0166	CcSEcCtD
Estropipate—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0054	0.0165	CcSEcCtD
Estropipate—Blister—Fluorouracil—head and neck cancer	0.00474	0.0145	CcSEcCtD
Estropipate—Neoplasm—Vinblastine—head and neck cancer	0.00471	0.0144	CcSEcCtD
Estropipate—Neoplasm—Hydroxyurea—head and neck cancer	0.00429	0.0131	CcSEcCtD
Estropipate—Polyp—Docetaxel—head and neck cancer	0.00405	0.0124	CcSEcCtD
Estropipate—Tenderness—Fluorouracil—head and neck cancer	0.00392	0.012	CcSEcCtD
Estropipate—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00386	0.0118	CcSEcCtD
Estropipate—Embolism—Docetaxel—head and neck cancer	0.00384	0.0117	CcSEcCtD
Estropipate—Cyst—Docetaxel—head and neck cancer	0.00369	0.0113	CcSEcCtD
Estropipate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00361	0.011	CcSEcCtD
Estropipate—Inflammation—Fluorouracil—head and neck cancer	0.00352	0.0108	CcSEcCtD
Estropipate—Neuritis—Docetaxel—head and neck cancer	0.0033	0.0101	CcSEcCtD
Estropipate—Breast disorder—Hydroxyurea—head and neck cancer	0.00311	0.00952	CcSEcCtD
Estropipate—Pancreatitis—Hydroxyurea—head and neck cancer	0.00292	0.00893	CcSEcCtD
Estropipate—Depression—Vinblastine—head and neck cancer	0.0029	0.00888	CcSEcCtD
Estropipate—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00287	0.00878	CcSEcCtD
Estropipate—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00287	0.00876	CcSEcCtD
Estropipate—Myocardial infarction—Vinblastine—head and neck cancer	0.00285	0.00873	CcSEcCtD
Estropipate—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00285	0.00873	CcSEcCtD
Estropipate—Amenorrhoea—Docetaxel—head and neck cancer	0.00281	0.00858	CcSEcCtD
Estropipate—Dysuria—Hydroxyurea—head and neck cancer	0.00279	0.00852	CcSEcCtD
Estropipate—Bone disorder—Docetaxel—head and neck cancer	0.00273	0.00835	CcSEcCtD
Estropipate—Weight increased—Hydroxyurea—head and neck cancer	0.00271	0.00829	CcSEcCtD
Estropipate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00266	0.00812	CcSEcCtD
Estropipate—Infestation—Hydroxyurea—head and neck cancer	0.00266	0.00812	CcSEcCtD
Estropipate—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0026	0.00796	CcSEcCtD
Estropipate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.0026	0.00794	CcSEcCtD
Estropipate—Pharyngitis—Vinblastine—head and neck cancer	0.00259	0.00793	CcSEcCtD
Estropipate—Inflammation—Docetaxel—head and neck cancer	0.00254	0.00778	CcSEcCtD
Estropipate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00251	0.00768	CcSEcCtD
Estropipate—Pulmonary embolism—Docetaxel—head and neck cancer	0.00247	0.00754	CcSEcCtD
Estropipate—Blood pressure increased—Docetaxel—head and neck cancer	0.00247	0.00754	CcSEcCtD
Estropipate—Irritability—Fluorouracil—head and neck cancer	0.00237	0.00724	CcSEcCtD
Estropipate—Fluid retention—Docetaxel—head and neck cancer	0.00234	0.00716	CcSEcCtD
Estropipate—Alopecia—Vinblastine—head and neck cancer	0.00231	0.00706	CcSEcCtD
Estropipate—Neoplasm—Docetaxel—head and neck cancer	0.00223	0.00682	CcSEcCtD
Estropipate—Angiopathy—Hydroxyurea—head and neck cancer	0.00216	0.00661	CcSEcCtD
Estropipate—Alopecia—Hydroxyurea—head and neck cancer	0.00211	0.00644	CcSEcCtD
Estropipate—Erythema—Hydroxyurea—head and neck cancer	0.00208	0.00635	CcSEcCtD
Estropipate—Thrombophlebitis—Docetaxel—head and neck cancer	0.00207	0.00632	CcSEcCtD
Estropipate—Vertigo—Vinblastine—head and neck cancer	0.00204	0.00625	CcSEcCtD
Estropipate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00199	0.00609	CcSEcCtD
Estropipate—Infestation NOS—Fluorouracil—head and neck cancer	0.00191	0.00585	CcSEcCtD
Estropipate—Infestation—Fluorouracil—head and neck cancer	0.00191	0.00585	CcSEcCtD
Estropipate—Visual disturbance—Docetaxel—head and neck cancer	0.00189	0.00578	CcSEcCtD
Estropipate—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00188	0.00576	CcSEcCtD
Estropipate—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00187	0.00573	CcSEcCtD
Estropipate—Myocardial infarction—Fluorouracil—head and neck cancer	0.00187	0.00573	CcSEcCtD
Estropipate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00187	0.00573	CcSEcCtD
Estropipate—Sinusitis—Fluorouracil—head and neck cancer	0.00179	0.00548	CcSEcCtD
Estropipate—Pain in extremity—Docetaxel—head and neck cancer	0.00179	0.00547	CcSEcCtD
Estropipate—Migraine—Docetaxel—head and neck cancer	0.00176	0.00539	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00175	0.00537	CcSEcCtD
Estropipate—Rhinitis—Fluorouracil—head and neck cancer	0.00172	0.00526	CcSEcCtD
Estropipate—Pharyngitis—Fluorouracil—head and neck cancer	0.0017	0.00521	CcSEcCtD
Estropipate—Oedema—Hydroxyurea—head and neck cancer	0.00169	0.00518	CcSEcCtD
Estropipate—Infection—Hydroxyurea—head and neck cancer	0.00168	0.00515	CcSEcCtD
Estropipate—Paraesthesia—Vinblastine—head and neck cancer	0.00167	0.0051	CcSEcCtD
Estropipate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00166	0.00508	CcSEcCtD
Estropipate—Skin disorder—Hydroxyurea—head and neck cancer	0.00165	0.00503	CcSEcCtD
Estropipate—Breast disorder—Docetaxel—head and neck cancer	0.00162	0.00495	CcSEcCtD
Estropipate—Cramp muscle—Docetaxel—head and neck cancer	0.00161	0.00493	CcSEcCtD
Estropipate—Pain—Vinblastine—head and neck cancer	0.00159	0.00486	CcSEcCtD
Estropipate—Constipation—Vinblastine—head and neck cancer	0.00159	0.00486	CcSEcCtD
Estropipate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00152	0.00464	CcSEcCtD
Estropipate—Alopecia—Fluorouracil—head and neck cancer	0.00152	0.00464	CcSEcCtD
Estropipate—Somnolence—Hydroxyurea—head and neck cancer	0.00151	0.0046	CcSEcCtD
Estropipate—Erythema—Fluorouracil—head and neck cancer	0.00149	0.00457	CcSEcCtD
Estropipate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00149	0.00456	CcSEcCtD
Estropipate—Abdominal pain—Vinblastine—head and neck cancer	0.00147	0.00449	CcSEcCtD
Estropipate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00146	0.00447	CcSEcCtD
Estropipate—Fatigue—Hydroxyurea—head and neck cancer	0.00146	0.00447	CcSEcCtD
Estropipate—Pain—Hydroxyurea—head and neck cancer	0.00145	0.00443	CcSEcCtD
Estropipate—Constipation—Hydroxyurea—head and neck cancer	0.00145	0.00443	CcSEcCtD
Estropipate—Weight increased—Docetaxel—head and neck cancer	0.00141	0.00431	CcSEcCtD
Estropipate—Infestation NOS—Docetaxel—head and neck cancer	0.00138	0.00422	CcSEcCtD
Estropipate—Infestation—Docetaxel—head and neck cancer	0.00138	0.00422	CcSEcCtD
Estropipate—Hypersensitivity—Vinblastine—head and neck cancer	0.00137	0.00418	CcSEcCtD
Estropipate—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00136	0.00416	CcSEcCtD
Estropipate—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00135	0.00414	CcSEcCtD
Estropipate—Myocardial infarction—Docetaxel—head and neck cancer	0.00135	0.00414	CcSEcCtD
Estropipate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00134	0.00409	CcSEcCtD
Estropipate—Asthenia—Vinblastine—head and neck cancer	0.00133	0.00407	CcSEcCtD
Estropipate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.0013	0.00399	CcSEcCtD
Estropipate—Myalgia—Fluorouracil—head and neck cancer	0.00127	0.00389	CcSEcCtD
Estropipate—Diarrhoea—Vinblastine—head and neck cancer	0.00127	0.00389	CcSEcCtD
Estropipate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00125	0.00382	CcSEcCtD
Estropipate—Rhinitis—Docetaxel—head and neck cancer	0.00124	0.0038	CcSEcCtD
Estropipate—Pharyngitis—Docetaxel—head and neck cancer	0.00123	0.00376	CcSEcCtD
Estropipate—Dizziness—Vinblastine—head and neck cancer	0.00123	0.00376	CcSEcCtD
Estropipate—Oedema peripheral—Docetaxel—head and neck cancer	0.00122	0.00373	CcSEcCtD
Estropipate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00122	0.00373	CcSEcCtD
Estropipate—Oedema—Fluorouracil—head and neck cancer	0.00122	0.00373	CcSEcCtD
Estropipate—Asthenia—Hydroxyurea—head and neck cancer	0.00122	0.00372	CcSEcCtD
Estropipate—Infection—Fluorouracil—head and neck cancer	0.00121	0.0037	CcSEcCtD
Estropipate—Nervous system disorder—Fluorouracil—head and neck cancer	0.0012	0.00366	CcSEcCtD
Estropipate—Visual impairment—Docetaxel—head and neck cancer	0.00119	0.00365	CcSEcCtD
Estropipate—Vomiting—Vinblastine—head and neck cancer	0.00118	0.00361	CcSEcCtD
Estropipate—Erythema multiforme—Docetaxel—head and neck cancer	0.00117	0.00358	CcSEcCtD
Estropipate—Headache—Vinblastine—head and neck cancer	0.00116	0.00356	CcSEcCtD
Estropipate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00116	0.00354	CcSEcCtD
Estropipate—Eye disorder—Docetaxel—head and neck cancer	0.00116	0.00354	CcSEcCtD
Estropipate—Cardiac disorder—Docetaxel—head and neck cancer	0.00115	0.00351	CcSEcCtD
Estropipate—Angiopathy—Docetaxel—head and neck cancer	0.00112	0.00344	CcSEcCtD
Estropipate—Dizziness—Hydroxyurea—head and neck cancer	0.00112	0.00342	CcSEcCtD
Estropipate—Immune system disorder—Docetaxel—head and neck cancer	0.00112	0.00342	CcSEcCtD
Estropipate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00112	0.00341	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00111	0.0034	CcSEcCtD
Estropipate—Nausea—Vinblastine—head and neck cancer	0.0011	0.00337	CcSEcCtD
Estropipate—Insomnia—Fluorouracil—head and neck cancer	0.0011	0.00337	CcSEcCtD
Estropipate—Paraesthesia—Fluorouracil—head and neck cancer	0.00109	0.00335	CcSEcCtD
Estropipate—Alopecia—Docetaxel—head and neck cancer	0.00109	0.00335	CcSEcCtD
Estropipate—Mental disorder—Docetaxel—head and neck cancer	0.00109	0.00332	CcSEcCtD
Estropipate—Somnolence—Fluorouracil—head and neck cancer	0.00108	0.00331	CcSEcCtD
Estropipate—Erythema—Docetaxel—head and neck cancer	0.00108	0.0033	CcSEcCtD
Estropipate—Malnutrition—Docetaxel—head and neck cancer	0.00108	0.0033	CcSEcCtD
Estropipate—Vomiting—Hydroxyurea—head and neck cancer	0.00108	0.00329	CcSEcCtD
Estropipate—Dyspepsia—Fluorouracil—head and neck cancer	0.00107	0.00328	CcSEcCtD
Estropipate—Rash—Hydroxyurea—head and neck cancer	0.00107	0.00327	CcSEcCtD
Estropipate—Dermatitis—Hydroxyurea—head and neck cancer	0.00107	0.00326	CcSEcCtD
Estropipate—Headache—Hydroxyurea—head and neck cancer	0.00106	0.00324	CcSEcCtD
Estropipate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00105	0.00322	CcSEcCtD
Estropipate—Back pain—Docetaxel—head and neck cancer	0.00104	0.00319	CcSEcCtD
Estropipate—Pain—Fluorouracil—head and neck cancer	0.00104	0.00319	CcSEcCtD
Estropipate—Muscle spasms—Docetaxel—head and neck cancer	0.00104	0.00317	CcSEcCtD
Estropipate—Nausea—Hydroxyurea—head and neck cancer	0.00101	0.00308	CcSEcCtD
Estropipate—Urticaria—Fluorouracil—head and neck cancer	0.000969	0.00296	CcSEcCtD
Estropipate—Body temperature increased—Fluorouracil—head and neck cancer	0.000964	0.00295	CcSEcCtD
Estropipate—Palpitations—Docetaxel—head and neck cancer	0.000953	0.00291	CcSEcCtD
Estropipate—Cough—Docetaxel—head and neck cancer	0.000941	0.00288	CcSEcCtD
Estropipate—Myalgia—Docetaxel—head and neck cancer	0.000918	0.00281	CcSEcCtD
Estropipate—Arthralgia—Docetaxel—head and neck cancer	0.000918	0.00281	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000912	0.00279	CcSEcCtD
Estropipate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000898	0.00275	CcSEcCtD
Estropipate—Oedema—Docetaxel—head and neck cancer	0.00088	0.00269	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—head and neck cancer	0.00088	0.00269	CcSEcCtD
Estropipate—Infection—Docetaxel—head and neck cancer	0.000874	0.00267	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—head and neck cancer	0.000863	0.00264	CcSEcCtD
Estropipate—Pruritus—Fluorouracil—head and neck cancer	0.000863	0.00264	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—head and neck cancer	0.000855	0.00261	CcSEcCtD
Estropipate—Diarrhoea—Fluorouracil—head and neck cancer	0.000834	0.00255	CcSEcCtD
Estropipate—Dizziness—Fluorouracil—head and neck cancer	0.000806	0.00247	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000802	0.00245	CcSEcCtD
Estropipate—Insomnia—Docetaxel—head and neck cancer	0.000796	0.00243	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—head and neck cancer	0.00079	0.00242	CcSEcCtD
Estropipate—Somnolence—Docetaxel—head and neck cancer	0.000782	0.00239	CcSEcCtD
Estropipate—Vomiting—Fluorouracil—head and neck cancer	0.000775	0.00237	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—head and neck cancer	0.000775	0.00237	CcSEcCtD
Estropipate—Rash—Fluorouracil—head and neck cancer	0.000769	0.00235	CcSEcCtD
Estropipate—Dermatitis—Fluorouracil—head and neck cancer	0.000768	0.00235	CcSEcCtD
Estropipate—Headache—Fluorouracil—head and neck cancer	0.000764	0.00234	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00076	0.00232	CcSEcCtD
Estropipate—Fatigue—Docetaxel—head and neck cancer	0.000759	0.00232	CcSEcCtD
Estropipate—Constipation—Docetaxel—head and neck cancer	0.000753	0.0023	CcSEcCtD
Estropipate—Pain—Docetaxel—head and neck cancer	0.000753	0.0023	CcSEcCtD
Estropipate—Estrone—CYP1A1—head and neck cancer	0.000737	0.569	CrCbGaD
Estropipate—Nausea—Fluorouracil—head and neck cancer	0.000724	0.00221	CcSEcCtD
Estropipate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00072	0.0022	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—head and neck cancer	0.000696	0.00213	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—head and neck cancer	0.000696	0.00213	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.000651	0.00342	CbGpPWpGaD
Estropipate—Hypersensitivity—Docetaxel—head and neck cancer	0.000648	0.00198	CcSEcCtD
Estropipate—Asthenia—Docetaxel—head and neck cancer	0.000631	0.00193	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000625	0.00328	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000625	0.00328	CbGpPWpGaD
Estropipate—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000625	0.00328	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000624	0.00328	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000624	0.00328	CbGpPWpGaD
Estropipate—Pruritus—Docetaxel—head and neck cancer	0.000623	0.0019	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00061	0.00321	CbGpPWpGaD
Estropipate—Diarrhoea—Docetaxel—head and neck cancer	0.000602	0.00184	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.000596	0.00313	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.000593	0.00312	CbGpPWpGaD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000591	0.00311	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00059	0.0031	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000588	0.00309	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000584	0.00307	CbGpPWpGaD
Estropipate—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000583	0.00306	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.000583	0.00306	CbGpPWpGaD
Estropipate—Dizziness—Docetaxel—head and neck cancer	0.000582	0.00178	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.000581	0.00305	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000568	0.00298	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000563	0.00296	CbGpPWpGaD
Estropipate—Vomiting—Docetaxel—head and neck cancer	0.00056	0.00171	CcSEcCtD
Estropipate—Estradiol—CYP1A1—head and neck cancer	0.000559	0.431	CrCbGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000559	0.00293	CbGpPWpGaD
Estropipate—Rash—Docetaxel—head and neck cancer	0.000555	0.0017	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—head and neck cancer	0.000554	0.0017	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.000553	0.0029	CbGpPWpGaD
Estropipate—Headache—Docetaxel—head and neck cancer	0.000551	0.00169	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000549	0.00288	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000548	0.00288	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000544	0.00286	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.000538	0.00282	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000537	0.00282	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000537	0.00282	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000536	0.00282	CbGpPWpGaD
Estropipate—Nausea—Docetaxel—head and neck cancer	0.000523	0.0016	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000517	0.00272	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000511	0.00268	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000505	0.00265	CbGpPWpGaD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000505	0.00265	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000505	0.00265	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000501	0.00263	CbGpPWpGaD
Estropipate—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000499	0.00262	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000487	0.00256	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000485	0.00255	CbGpPWpGaD
Estropipate—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000482	0.00253	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.000479	0.00252	CbGpPWpGaD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000479	0.00252	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000465	0.00244	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000464	0.00244	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.00046	0.00241	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000459	0.00241	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000458	0.00241	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.000456	0.0024	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.000456	0.0024	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000443	0.00233	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00044	0.00231	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—RARB—head and neck cancer	0.000439	0.0023	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000422	0.00222	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000418	0.0022	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000417	0.00219	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000416	0.00219	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000412	0.00216	CbGpPWpGaD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00041	0.00215	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—UROD—head and neck cancer	0.000409	0.00215	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000407	0.00214	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—YAP1—head and neck cancer	0.000399	0.0021	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000396	0.00208	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000396	0.00208	CbGpPWpGaD
Estropipate—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000392	0.00206	CbGpPWpGaD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00039	0.00205	CbGpPWpGaD
Estropipate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000385	0.00202	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000374	0.00197	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000374	0.00196	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000372	0.00195	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL2—head and neck cancer	0.000369	0.00194	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000359	0.00188	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000358	0.00188	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000354	0.00186	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000348	0.00183	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000346	0.00181	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000344	0.00181	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000344	0.00181	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000339	0.00178	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000332	0.00175	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000323	0.0017	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000316	0.00166	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000316	0.00166	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000307	0.00161	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000307	0.00161	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000299	0.00157	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000296	0.00156	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000296	0.00156	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000295	0.00155	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000293	0.00154	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000282	0.00148	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000281	0.00148	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000281	0.00147	CbGpPWpGaD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000277	0.00145	CbGpPWpGaD
Estropipate—ALB—Metabolism—UROD—head and neck cancer	0.000274	0.00144	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000269	0.00141	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000269	0.00141	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000268	0.00141	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000265	0.00139	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000263	0.00138	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000263	0.00138	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000263	0.00138	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000256	0.00134	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000255	0.00134	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000254	0.00134	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000252	0.00132	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000251	0.00132	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000246	0.00129	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000241	0.00127	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000241	0.00127	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.00024	0.00126	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.00024	0.00126	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—head and neck cancer	0.000237	0.00124	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000229	0.00121	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000226	0.00119	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—UROD—head and neck cancer	0.000224	0.00118	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000222	0.00117	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—RARB—head and neck cancer	0.000221	0.00116	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000218	0.00114	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000215	0.00113	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000212	0.00111	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000212	0.00111	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00021	0.0011	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000208	0.00109	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000202	0.00106	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—YAP1—head and neck cancer	0.000201	0.00106	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.0002	0.00105	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.0002	0.00105	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000192	0.00101	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—UROD—head and neck cancer	0.000191	0.00101	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000188	0.00099	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000185	0.000972	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—NOTCH1—head and neck cancer	0.00018	0.000945	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000177	0.00093	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000175	0.000917	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000174	0.000913	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000174	0.000913	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000173	0.00091	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000171	0.000897	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.00017	0.000893	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NAT2—head and neck cancer	0.00017	0.000892	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000168	0.000882	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000168	0.000881	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000166	0.00087	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000152	0.0008	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—DPYD—head and neck cancer	0.000149	0.000782	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000148	0.00078	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000148	0.000777	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—UROD—head and neck cancer	0.000148	0.000776	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000142	0.000744	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—YAP1—head and neck cancer	0.000141	0.000742	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00014	0.000737	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000139	0.000733	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—MAPK1—head and neck cancer	0.000133	0.000699	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000131	0.000688	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000121	0.000634	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000119	0.000627	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000119	0.000626	CbGpPWpGaD
Estropipate—ALB—Metabolism—NAT2—head and neck cancer	0.000114	0.000597	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000113	0.000592	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000107	0.000564	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—head and neck cancer	0.000107	0.000561	CbGpPWpGaD
Estropipate—ALB—Metabolism—DPYD—head and neck cancer	9.96e-05	0.000523	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MAPK3—head and neck cancer	9.95e-05	0.000523	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.87e-05	0.000519	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.78e-05	0.000513	CbGpPWpGaD
Estropipate—ALB—Metabolism—YAP1—head and neck cancer	9.45e-05	0.000497	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	9.31e-05	0.000489	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NAT2—head and neck cancer	9.3e-05	0.000488	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NOTCH1—head and neck cancer	9.07e-05	0.000477	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TYMS—head and neck cancer	8.48e-05	0.000446	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.44e-05	0.000443	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—head and neck cancer	8.39e-05	0.000441	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.35e-05	0.000439	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—DPYD—head and neck cancer	8.15e-05	0.000428	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GPX1—head and neck cancer	8.03e-05	0.000422	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1A1—head and neck cancer	7.95e-05	0.000418	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NAT2—head and neck cancer	7.95e-05	0.000417	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—YAP1—head and neck cancer	7.74e-05	0.000406	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	7.61e-05	0.0004	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—head and neck cancer	7.23e-05	0.00038	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.1e-05	0.000373	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—DPYD—head and neck cancer	6.97e-05	0.000366	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—head and neck cancer	6.71e-05	0.000353	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—YAP1—head and neck cancer	6.61e-05	0.000347	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.19e-05	0.000325	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—head and neck cancer	6.15e-05	0.000323	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NAT2—head and neck cancer	6.13e-05	0.000322	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	5.9e-05	0.00031	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.81e-05	0.000305	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—head and neck cancer	5.81e-05	0.000305	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—head and neck cancer	5.68e-05	0.000298	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—head and neck cancer	5.61e-05	0.000295	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK1—head and neck cancer	5.53e-05	0.000291	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—DPYD—head and neck cancer	5.38e-05	0.000282	CbGpPWpGaD
Estropipate—ALB—Metabolism—GPX1—head and neck cancer	5.37e-05	0.000282	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—head and neck cancer	5.32e-05	0.000279	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—YAP1—head and neck cancer	5.1e-05	0.000268	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.07e-05	0.000266	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—head and neck cancer	5.02e-05	0.000264	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.97e-05	0.000261	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—head and neck cancer	4.8e-05	0.000252	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—head and neck cancer	4.73e-05	0.000248	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—head and neck cancer	4.65e-05	0.000244	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—head and neck cancer	4.64e-05	0.000244	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.59e-05	0.000241	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—head and neck cancer	4.44e-05	0.000233	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPX1—head and neck cancer	4.4e-05	0.000231	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.37e-05	0.00023	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.35e-05	0.000229	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.33e-05	0.000228	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—head and neck cancer	4.12e-05	0.000217	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—head and neck cancer	4.06e-05	0.000213	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—head and neck cancer	3.97e-05	0.000209	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—head and neck cancer	3.96e-05	0.000208	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.92e-05	0.000206	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—head and neck cancer	3.92e-05	0.000206	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—head and neck cancer	3.82e-05	0.000201	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPX1—head and neck cancer	3.76e-05	0.000197	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.72e-05	0.000195	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.58e-05	0.000188	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—head and neck cancer	3.45e-05	0.000181	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—head and neck cancer	3.42e-05	0.000179	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—head and neck cancer	3.39e-05	0.000178	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—head and neck cancer	3.26e-05	0.000171	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—head and neck cancer	3.16e-05	0.000166	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK1—head and neck cancer	3.11e-05	0.000163	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—head and neck cancer	3.1e-05	0.000163	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—head and neck cancer	3.06e-05	0.000161	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.06e-05	0.000161	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.03e-05	0.000159	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—head and neck cancer	2.91e-05	0.000153	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPX1—head and neck cancer	2.9e-05	0.000152	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.87e-05	0.000151	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—head and neck cancer	2.76e-05	0.000145	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	2.69e-05	0.000142	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—head and neck cancer	2.61e-05	0.000137	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.59e-05	0.000136	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—head and neck cancer	2.49e-05	0.000131	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—head and neck cancer	2.38e-05	0.000125	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—head and neck cancer	2.26e-05	0.000119	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.21e-05	0.000116	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—head and neck cancer	2.2e-05	0.000116	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—head and neck cancer	1.95e-05	0.000102	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—head and neck cancer	1.93e-05	0.000101	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.71e-05	8.97e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.59e-05	8.37e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—head and neck cancer	1.59e-05	8.35e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—head and neck cancer	1.49e-05	7.82e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.36e-05	7.15e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—head and neck cancer	1.3e-05	6.83e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—head and neck cancer	1.11e-05	5.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.05e-05	5.52e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—head and neck cancer	8.58e-06	4.51e-05	CbGpPWpGaD
